NCT00839202View on ClinicalTrials.gov

Activity and Content of Factor VIII (FVIII) in Human Plasma: The Assessment of a Novel Immunoassay

NACompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

September 30, 2008

Study Completion Date

February 28, 2009

Conditions
Hemophilia A
Interventions
OTHER

FVIII immuno-assay

There is no intervention. This is a study of the differences in assays.

Trial Locations (1)

05446

Department of Biochemistry University of Vermont, Burlington

All Listed Sponsors
collaborator

University of Vermont

OTHER

lead

Children's Hospital Los Angeles

OTHER

NCT00839202 - Activity and Content of Factor VIII (FVIII) in Human Plasma: The Assessment of a Novel Immunoassay | Biotech Hunter | Biotech Hunter